Investeringsoversigt
6161 Investeringer
| Titel Sortér faldende | Periode | Program | |
|---|---|---|---|
| A new approach to understand how lifestyle influences the activity among people with Multiple sclerosis using a person centered design | 2016 - 2019 | Erhvervsforsker
|
|
|
A new approach to understand how lifestyle influences the activity among people with Multiple sclerosis using a person centered design
Periode
2016 - 2019
Region
Region Hovedstaden Program
Erhvervsforsker Fagområde
Ikke defineret Investering
Percentage
40.89 Fondens investering
948.746 Samlet budget
2,3 mio. Projektdeltagere
University of Copenhagen, SCLEROSEFORENINGEN Projektleder
SCLEROSEFORENINGEN
Læs mere om projektet
| |||
| A new cost-neutral injection pen as an alternative to syringes for the 12 million resource poor people buying insulin in vials though minimum feature innovation | 2019 - 2020 | Innofounder
|
|
|
A new cost-neutral injection pen as an alternative to syringes for the 12 million resource poor people buying insulin in vials though minimum feature innovation
Periode
2019 - 2020
Region
Region Hovedstaden Program
Innofounder Fagområde
Biotek, Medico og Sundhed Investering
Percentage
100 Fondens investering
460.000 Samlet budget
460.000 Projektdeltagere
GO-PEN ApS Projektleder
GO-PEN ApS
Læs mere om projektet
| |||
| A new generation of Pattern Scanning Photocoagulator systems for multi-spot laser treatment of ophthalmic diseases | 2021 - 2023 | Innobooster
|
|
|
A new generation of Pattern Scanning Photocoagulator systems for multi-spot laser treatment of ophthalmic diseases
Periode
2021 - 2023
Region
Region Hovedstaden Program
Innobooster Fagområde
Ikke defineret Investering
Percentage
33 Fondens investering
4,4 mio. Samlet budget
13,2 mio. Projektdeltagere
Norlase Aps Projektleder
NORLASE ApS
Læs mere om projektet
| |||
| A new peptide-drug conjugate for obesity treatment | 2022 - 2024 | Innobooster
|
|
|
A new peptide-drug conjugate for obesity treatment
Periode
2022 - 2024
Region
Region Hovedstaden Program
Innobooster Fagområde
Ikke defineret Investering
Percentage
32.7 Fondens investering
1,5 mio. Samlet budget
4,5 mio. Projektdeltagere
Ousia Pharma ApS Projektleder
Ousia Pharma ApS
Læs mere om projektet
| |||
| A new stability framework for complex blades in 3D flow | 2022 - 2024 | Erhvervsforsker
|
|
|
A new stability framework for complex blades in 3D flow
Periode
2022 - 2024
Region
Region Syddanmark Program
Erhvervsforsker Fagområde
Ikke defineret Investering
Percentage
57.36 Fondens investering
1,1 mio. Samlet budget
1,9 mio. Projektdeltagere
Technical University of Denmark, LM WIND POWER A/S Projektleder
LM WIND POWER A/S
Læs mere om projektet
| |||
| A new treatment of cardiac arrest | 2016 - 2017 | Innobooster
|
|
|
A new treatment of cardiac arrest
Periode
2016 - 2017
Region
Region Hovedstaden Program
Innobooster Fagområde
Ikke defineret Investering
Percentage
34.98 Fondens investering
496.081 Samlet budget
1,4 mio. Projektdeltagere
NEURESCUE ApS Projektleder
NEURESCUE ApS
Læs mere om projektet
| |||
| A new type of white light-emitting diode using fluorescent silicon carbide (LEDSiC) | 2015 - 2019 | Grand Solutions
|
|
|
A new type of white light-emitting diode using fluorescent silicon carbide (LEDSiC)
Periode
2015 - 2019
Region
Program
Grand Solutions Fagområde
Energi, Klima og Miljø Investering
Percentage
75.61 Fondens investering
8,7 mio. Samlet budget
11,5 mio. Projektdeltagere
Technical University of Denmark - Fotonik, Technical University of Denmark - Danchip, Fudan University, Institute of Semiconductors, Linköping University, Erlangen University, Topsii, Light extraction Projektleder
Aktiv
Læs mere om projektet
| |||
| A novel 3D ultrasound technique to assess surgical margins in cancer surgery | 2022 - 2023 | Innoexplorer
|
|
|
A novel 3D ultrasound technique to assess surgical margins in cancer surgery
Periode
2022 - 2023
Region
Region Hovedstaden Program
Innoexplorer Fagområde
Ikke defineret Investering
Percentage
100 Fondens investering
1,5 mio. Samlet budget
1,5 mio. Projektdeltagere
RIGSHOSPITALET Projektleder
RIGSHOSPITALET
Læs mere om projektet
| |||
| A novel antibiotic for the fight against multiresistant bacteria | 2021 - 2022 | Innoexplorer
|
|
|
A novel antibiotic for the fight against multiresistant bacteria
Periode
2021 - 2022
Region
Region Syddanmark Program
Innoexplorer Fagområde
Ikke defineret Investering
Percentage
100 Fondens investering
1,5 mio. Samlet budget
1,5 mio. Projektdeltagere
Syddansk Universitet Projektleder
Syddansk Universitet
Læs mere om projektet
| |||
| A novel antimicrobial therapy in cystic fibrosis: preclinical safety | 2019 - 2019 | Innobooster
|
|
|
A novel antimicrobial therapy in cystic fibrosis: preclinical safety
Periode
2019 - 2019
Region
Region Hovedstaden Program
Innobooster Fagområde
Ikke defineret Investering
Percentage
22.56 Fondens investering
1,0 mio. Samlet budget
4,5 mio. Projektdeltagere
Adenium Biotech ApS Projektleder
ADENIUM BIOTECH ApS
Læs mere om projektet
| |||
| A novel approach for full workflow automation in aerial 360° videography | 2018 - 2018 | Innobooster
|
|
|
A novel approach for full workflow automation in aerial 360° videography
Periode
2018 - 2018
Region
Region Hovedstaden Program
Innobooster Fagområde
Ikke defineret Investering
Percentage
30.66 Fondens investering
224.450 Samlet budget
732.000 Projektdeltagere
Absolute Zero ApS Projektleder
Immersive Technologies ApS
Læs mere om projektet
| |||
| A novel ceramic processing method for green hydrogen production | 2021 - 2024 | Erhvervsforsker
|
|
|
A novel ceramic processing method for green hydrogen production
Periode
2021 - 2024
Region
Region Sjælland Program
Erhvervsforsker Fagområde
Ikke defineret Investering
Percentage
57.02 Fondens investering
1,1 mio. Samlet budget
1,9 mio. Projektdeltagere
Technical University of Denmark, DynElectro ApS Projektleder
DynElectro ApS
Læs mere om projektet
| |||
| A Novel Humanized Mouse Model of Psoriasis | 2017 - 2022 | Erhvervsforsker
|
|
|
A Novel Humanized Mouse Model of Psoriasis
Periode
2017 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Fagområde
Biotek, Medico og Sundhed Investering
Percentage
41.55 Fondens investering
1,1 mio. Samlet budget
2,6 mio. Projektdeltagere
University of Copenhagen, LEO PHARMA A/S Projektleder
LEO PHARMA A/S
Læs mere om projektet
| |||
| A novel microbial expression system for production of single-domain antibodies | 2022 - 2024 | Erhvervsforsker
|
|
|
A novel microbial expression system for production of single-domain antibodies
Periode
2022 - 2024
Region
Region Hovedstaden Program
Erhvervsforsker Fagområde
Ikke defineret Investering
Percentage
45.1 Fondens investering
828.000 Samlet budget
1,8 mio. Projektdeltagere
Technical University of Denmark, Bactolife ApS Projektleder
Bactolife ApS
Læs mere om projektet
| |||
| A Novel Self-Testing and Disease Management Solution for Thyroid Patients | 2022 - 2022 | Innobooster
|
|
|
A Novel Self-Testing and Disease Management Solution for Thyroid Patients
Periode
2022 - 2022
Region
Region Hovedstaden Program
Innobooster Fagområde
Ikke defineret Investering
Percentage
35 Fondens investering
1,4 mio. Samlet budget
4,0 mio. Projektdeltagere
HEI Therapeutics Aps Projektleder
HEI Therapeutics ApS
Læs mere om projektet
| |||